Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven'sTerms andPolicy

Already have an account? Login here

BITCOIN CANNABIS CRYPTOCURRENCY ETFS EARNINGS FIXED INCOME

FUTURES OPTIONS

Home

BITCOIN
CANNABIS
CRYPTOCURRENCY
EARNINGS
ETFs
FIXED INCOME
FUNDS
FUTURES
OPTIONS
REITs
STOCKS

INVESTING

No More Tears for Johnson & Johnson?

FDA Reveals Details of Problems at Third-Party Maker of JNJ Shot

By Adam Smith

Canadian Tennis Player Milos Raonic Visits the NYSE and Says He's Ready for the U.S. Open

Cramer's Mad Money Recap: Game Plan

By Scott Rutt

Magnachip Remains Independent But Cost Cuts Could Help

5 Top Stock Gainers for Friday: Novan, Magnachip, Vaxart

By Rob Lenihan

Boeing 737 MAX: China's Flight Ban Won't Be Lifted Until Safety Concerns 'properly Addressed'

Boeing Reportedly Shrinks 737 MAX Jet Inventory to 10

By Dan Weil

Jim Cramer Stock Market Breakdown 12/2

Stock Market Today With Jim Cramer: Taxes and Meme Stocks

By Tony Owusu

061021_Cramer on Momentum Stocks

Jim Cramer's Principles For Investing in Momentum Stocks Safely

Incyte Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals

Incyte Sees Delay in FDA Review of Eczema Cream

By Dan Weil

Medallia CEO on Path to Profitability Post-IPO

Medallia Soars on Report It's Exploring a Sale

By Rob Lenihan

AMC Theatres Lead

AMC, BlackBerry or Workhorse - What's Your Meme Stock Preference?

By Bret Kenwell

Reopening Hong Kong-mainland Travel Top Of Carrie Lam's Wish List As City Leader Heads To Beijing For Talks

Real Money Pros Share Their Picks for Reopening Stocks

Dave and Buster's CEO Teases Expanding Overseas Following Its IPO

Trading Dave & Buster’s Earnings: Key Support and Resistance Are Clear

By Bret Kenwell

Amazon Rivian Lead

House Members Are Said Proposing to Split Amazon, Alphabet, Apple, Facebook

By Dan Weil

Billionaire Li Ka-shing's Biotech Unit Hopes For New Cancer Drug Approvals, Expands Sales Army In China Amid Stock Rally In London

Curis Drops; Lower Dose of Leukemia Drug to Reach Phase 2 Study

By Tony Owusu

Terms Of Use
Privacy Policy
Advertise
Market Holidays 2021
Customer Service
Data
Topic Archive
Subscriptions

© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.